Cibc Asset Management Inc Adaptive Biotechnologies Corp Transaction History

Cibc Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$30.02 - $39.87 $152,861 - $203,018	-5,092 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$37.26 - $67.74 $18,369 - $33,395	493 Added 10.72%	5,092 $205,000
Q3 2020 Nov 05, 2020	BUY	$35.79 - $48.81 $4,080 - $5,564	114 Added 2.54%	4,599 $224,000
Q2 2020 Jul 28, 2020	BUY	$24.95 - $48.38 $111,900 - $216,984	4,485 New	4,485 $217,000

225

146M

19.6K

27.2K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.2B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.